Off-Label Use of Dalbavancin for Sequential Treatment of Spondylodiscitis by Methicillin-Resistant <i>Staphylococcus aureus</i>: A Retrospective Single-Centre Experience

• Main Authors: Maria Mazzitelli (Author), Milo Gatti (Author), Vincenzo Scaglione (Author), Daniele Mengato (Author), Marco Trevenzoli (Author), Andrea Sattin (Author), Federico Pea (Author), Anna Maria Cattelan (Author)
• Format: Book
• Published: MDPI AG, 2022-10-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

<b>Background:</b> Our aim was to describe the clinical outcome and safety of the sequential treatment with off-label dalbavancin in patients with spondylodiscitis that is caused by methicillin-resistant <i>Staphylococcus aureus</i> (MRSA). <b>Methods</b>: We retr...